608 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
GSK GlaxoSmithKline PLC $39.21 $97.25B N/A
Article Searches
Top Research Reports for Facebook, Netflix & NextEra Energy http://www.zacks.com/research-daily/773289/top-research-reports-for-facebook-netflix-nextera-energy?cid=CS-ZC-FT-research_daily-773289 Feb 19, 2020 - Top Research Reports for Facebook, Netflix & NextEra Energy
Sanofi, J&J Join Forces With BARDA for Coronavirus Vaccine http://www.zacks.com/stock/news/773194/sanofi-jj-join-forces-with-barda-for-coronavirus-vaccine?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-773194 Feb 19, 2020 - Sanofi (SNY) and J&J (JNJ) sign deals with BARDA, part of U.S. Department of Health and Human Services, for accelerated development of a vaccine for the newly found coronavirus.
FDA Approves 3 Drugs for the Switch From Prescription to Over the Counter https://www.fool.com/investing/2020/02/17/fda-approves-3-drugs-for-switch-from-prescription.aspx?source=iedfolrf0000001 Feb 17, 2020 - The switch will increase the availability of pain and allergy drugs from GlaxoSmithKline and Alcon.
Gilead's BLA for CAR T Cell Therapy Gets FDA Acceptance http://www.zacks.com/stock/news/760081/gileads-bla-for-car-t-cell-therapy-gets-fda-acceptance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-760081 Feb 11, 2020 - The FDA accepts Gilead's (GILD) BLA for its second CAR T cell therapy, KTE-X19.
Pharma Stock Roundup: BMY, GSK, SNY Q4 Results, MRK Earnings & Split http://www.zacks.com/stock/news/754444/pharma-stock-roundup-bmy-gsk-sny-q4-results-mrk-earnings-split?cid=CS-ZC-FT-analyst_blog|stock_roundup-754444 Feb 07, 2020 - Merck (MRK), Bristol Myers (BMY), Sanofi (SNY), Glaxo (GSK) and Novo Nordisk (NVO) announce Q4 results.
GlaxoSmithKline Cutting Up to 720 Jobs at European Vaccine Facility https://www.fool.com/investing/2020/02/06/glaxosmithkline-cutting-up-to-720-jobs-at-european.aspx?source=iedfolrf0000001 Feb 06, 2020 - The workforce reduction is one of the moves being made to prepare for the pharmaceutical company's upcoming split into two entities.
GlaxoSmithKline plc (GSK) Q4 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2020/02/06/glaxosmithkline-plc-gsk-q4-2019-earnings-call-tran.aspx?source=iedfolrf0000001 Feb 06, 2020 - GSK earnings call for the period ending December 31, 2019.
GlaxoSmithKline plc (GSK) CEO Emma Walmsley on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4321765-glaxosmithkline-plc-gsk-ceo-emma-walmsley-on-q4-2019-results-earnings-call-transcript?source=feed_sector_healthcare Feb 05, 2020 - GlaxoSmithKline plc (NYSE:GSK) Q4 2019 Results Earnings Conference Call February 05, 2020, 9:00 am ET Company Participants Sarah Elton-Farr - Head of Global Investor Relations Emma Walmsley - Chief Ex
GlaxoSmithKline Predicts a 2020 Loss, Prepares for Its Consumer Spinoff https://www.fool.com/investing/2020/02/05/glaxosmithkline-predicts-a-loss-in-2020-prepares-f.aspx?source=iedfolrf0000001 Feb 05, 2020 - The pharmaceutical giant's fourth-quarter 2019 earnings were disappointing, but there were things for investors to smile about in the new details on its upcoming spinoff.
Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat http://www.zacks.com/stock/news/750461/gilead-gild-q4-earnings-miss-estimates-revenues-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-750461 Feb 05, 2020 - Gilead's (GILD) earnings fall short of estimates but sales beat the same in the fourth quarter of 2019.

Pages: 123456...61

Page 1>